Dina Schneider
Dina Schneider publishes mostly in Oncology, Immunology and Molecular Biology, on topics such as CAR-T cell therapy research, Viral Infectious Diseases and Gene Expression in Insects and Biosimilars and Bioanalytical Methods.
- World rank
- #303,791 of 7,710,434 ranked researchers
- Rank in United States
- #110,158 of 1,627,098
- Works
- 131
- Citations
- 3.4k
- Citations per work
- 26.1
What does Dina Schneider research?
Dina Schneider's work is mostly in Medicine (41%), Biochemistry, Genetics and Molecular Biology (19%), Immunology and Microbiology (17%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences5441.4%
- Medicine5441.4%
- Life Sciences4736.2%
- Everything else2922.4%
- 1Oncology36% of their works
- 2Immunology17% of their works
- 3Molecular Biology14% of their works
- 4Genetics5% of their works
- 5Radiology, Nuclear Medicine and Imaging3% of their works
- 6Epidemiology3% of their works
Research topics
- CAR-T cell therapy research
- Viral Infectious Diseases and Gene Expression in Insects
- Biosimilars and Bioanalytical Methods
- Virus-based gene therapy research
- Immune Cell Function and Interaction
- Monoclonal and Polyclonal Antibodies Research
- Respiratory viral infections research
- Acute Lymphoblastic Leukemia research
Which keywords describe Dina Schneider's research?
The keywords of their largest research topics: CAR T Cells, Chimeric Antigen Receptor, Glycosylation, Mammalian Cells, Monoclonal Antibodies, Recombinant Protein, Biosimilars and Immunogenicity.
- Respiratory Syncytial Virus
- Childhood Cancer
- Therapeutic Antibodies
- Natural Killer Cells
- Viral Vectors
- Immunogenicity
- Recombinant Protein
- Mammalian Cells
- Chimeric Antigen Receptor
- CAR T Cells
- Glycosylation
- Monoclonal Antibodies
- Biosimilars
- Gene Therapy
- NK Cell Recognition
- Fc Receptors
- Acute Lymphoblastic Leukemia
- Human Metapneumovirus
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 18 words, with their numbers
- CAR T Cells1001 topic
- Chimeric Antigen Receptor1001 topic
- Glycosylation372 topics
- Mammalian Cells281 topic
- Monoclonal Antibodies282 topics
- Recombinant Protein281 topic
- Biosimilars191 topic
- Immunogenicity191 topic
- Gene Therapy151 topic
- Viral Vectors151 topic
- NK Cell Recognition101 topic
- Natural Killer Cells101 topic
- Fc Receptors91 topic
- Therapeutic Antibodies91 topic
- Acute Lymphoblastic Leukemia71 topic
- Childhood Cancer71 topic
- Human Metapneumovirus71 topic
- Respiratory Syncytial Virus71 topic
Where does Dina Schneider work?
Dina Schneider's main affiliation in the publication record is Lentigen Technology (United States), United States.
How many publications and citations does Dina Schneider have?
OpenAlex counts 131 works and 3,419 citations for Dina Schneider, an h-index of 25, ranking #303,791 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Dina Schneider. Posts are plain text and can be reported.